Leukemia Research
Volume 27, Issue 1 , Pages 65-72 , January 2003

Effects of flavonoids on cisplatin-induced apoptosis of HL-60 and L1210 leukemia cells

  • Luboš Čipák

      Affiliations

    • Cancer Research Institute, Vlárska 7, 833 91 Bratislava, Slovak Republic
  • ,
  • Peter Rauko

      Affiliations

    • Cancer Research Institute, Vlárska 7, 833 91 Bratislava, Slovak Republic
    • Corresponding Author InformationCorresponding author. Tel.: +421-2-59327-105; fax: +421-2-59327-250.
  • ,
  • Eva Miadoková

      Affiliations

    • Department of Genetics, Faculty of Sciences, Comenius University, Mlynská dolina, 842 15 Bratislava, Slovak Republic
  • ,
  • Ingrid Čipáková

      Affiliations

    • Institute of Molecular Biology, Dubravská cesta 21, 842 51 Bratislava, Slovak Republic
  • ,
  • Ladislav Novotný

      Affiliations

    • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Kuwait University, P.O. Box 24923 Safat, 13110 Kuwait

Received 7 January 2002 ,Accepted 1 April 2002.

References 

  1. Stavric B. Antimutagens and anticarcinogens in foods. Food Chem. Toxicol. 1994;32:79
  2. Agullo G, Gamet-Payrastre L, Manenti S, Viala C, Rémésy C, Chap H, et al.  Relationship between flavonoid structure and inhibition of phosphatidyl-inositol-3 kinase: a comparison with tyrosine kinase and protein kinase C inhibition. Biochem. Pharma. 1997;53:1649
  3. Lee YJ, Erdos G, Hou Z, Kim SH, Kim JH, Cho JM, et al.  Mechanism of quercetin-induced suppression and delay of heat shock gene expression and thermotolerance development in HT-29 cells. Mol. Cell Biochem. 1994;137:141
  4. Kang T, Liang N. Studies on the inhibitory effects of quercetin on the growth of HL-60 leukemia cells. Biochem. Pharma. 1997;54:1013
  5. Lepley DM, Pelling JC. Induction of P21/WAF 1 and G1 cell-cycle arrest by the chemopreventive agent apigenin. Mol. Carcinogen. 1997;19:74
  6. Lepley DM, Li B, Birt DF, Pelling JC. The chemopreventive flavonoid apigenin induces G2/M arrest in keratynocytes. Carcinogenesis. 1996;17:2367
  7. Scambia G, Ranelletti FO, Panici B, Piantelli M, De Vincenzo R, Ferrandina G, et al.  Quercetin induces type-II estrogen-binding sites in estrogen-receptor negative (MDA6MB231) and estrogen-receptor-positive (MCF7) human breast-cancer cell lines. Int. J. Cancer. 1993;54:462
  8. Kuntz S, Wenzel U, Daniel H. Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity, and apoptosis in human colon cancer cell lines. Eur. J. Nutr. 1999;38:133
  9. Wang IK, Lin-Shiau SY, Lin JK. Induction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and caspase-3 in leukaemia HL-60 cells. Eur. J. Cancer. 1999;35:1517
  10. Wenzel U, Kuntz S, Brendel MD, Daniel H. Dietary flavone is a potent apoptosis inducer in human colon carcinoma cells. Cancer Res. 2000;60:3823
  11. Scambia G, Ranelletti FO, Benedetti Panici P, Bonanno G, De Vincenzo R, Piantelli M, et al.  Synergistic antiproliferative activity of quercetin and cisplatin on ovarian cancer cell growth. Anticancer Drugs. 1990;1:45
  12. Scambia G, Ranelletti FO, Panici PB, De Vincenzo R, Bonanno G, Ferrandina G, et al.  Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target. Cancer Chemother. Pharmacol. 1994;34:459
  13. Courage C, Budworth J, Gescher A. Comparison of ability of protein kinase C inhibitors to arrest cell growth and to alter cellular protein kinase C localization. Br. J. Cancer. 1995;71:697
  14. Carmichael J, Degraff WG, Gazdar AF, Minna JD, Mitchell JB. Evaluation of tetrazolium-based semiautomated colorometric assays: assessment of chemisensitivity Testing. Cancer Res. 1987;47:936
  15. Szekeres T, Fritzer M, Strobl H, Gharehbaghi K, Findenig G, Elford HL, et al.  Synergistic growth inhibitory and differentiating effects of trimidox and tiazofurin in human promyelocytic leukemia HL-60 cells. Blood. 1994;84:4316
  16. Chou TC, Talalay P. Analysis of combined drug effects: a new look at a very old problem. Trends Pharmacol. Sci. 1983;4:450
  17. Evans DL, Tilby M, Dive C. Differential sensitivity to the induction of apoptosis by cisplatin in proliferating and quiescent immature rat thymocytes is independent of the levels of drug accumulation and DNA adduct formation. Cancer Res. 1994;54:1596
  18. Rauko P, Novotny L, Dovinova I, Hunakova L, Szekeres T, Jayaram HN. Antitumor activity of benzamide riboside and its combination with cisplatin and staurosporine. Eur. J. Pharm. Sci. 2001;12:387
  19. Heo MY, Sohn SJ, Au WW. Anti-genotoxicity of galangin as a cancer chemopreventive agent candidate. Mutat. Res. 2001;488:135
  20. Čipak L, Miadokova E, Dingova H, Kogan G, Novotny L, Rauko P. Comparative DNA protectivity and antimutagenicity studies using DNA-topology and Ames assays. Toxicol. In Vitro. 2001;15:677
  21. Romanova D, Vachalkova A, Čipak L, Ovesna Z, Rauko P. Study of antioxidant effect of apigenin, luteolin and quercetin by DNA protective method. Neoplasma. 2001;48:104
  22. Rauko P, Sedlak J, Duraj J, Szekeres MF, Novotný L. Pentoxifylline stimulates drug-induced apoptosis in leukemic cells. Neoplasma. 1998;45:296
  23. Sohn SJ, Huh IH, Au WW, Heo MY. Antigenotoxicity of galangin against N-methyl-N-nitrosourea. Mutat. Res. 1998;402:231
  24. Quadri SA, Quadri AN, Hahn ME, Mann KK, Sherr DH. The bioflavonoid galangin blocks aryl hydrocarbon receptor activation and polycyclic aromatic hydrocarbon-induced pre-B-cell apoptosis. Mol. Pharmacol. 2000;58:515
  25. Cifone MG, Migliorati G, Parroni R, Marchetti C, Millimaggi D, Santoni A, et al.  Dexamethasone-induced thymocyte apoptosis: Apoptotic signal involves the sequential activation of phosphoinositide-specific phospholipase C, acidic sphingomyelinase, and caspases. Blood. 1999;93:2282
  26. Kuhlmann MK, Horsch E, Burkhardt G, Wagner M, Kohler H. Reduction of cisplatin toxicity in cultured renal tubular cells by the bioflavonoid quercetin. Arch Toxicol. 1998;72:536
  27. Cross HJ, Tilby M, Chipman JK, Ferry DR, Gescher A. Effect of quercetin on the genotoxic potential of cisplatin. Int. J. Cancer. 1996;66:404
  28. Hofmann J, Doppler W, Jakob A, Maly K, Posch L, Uberall F, et al.  Enhancement of the antiproliferative effect of cis-diamminedichloro-platinum(II) and nitrogen mustard by inhibitors of protein kinase C. Int. J. Cancer. 1988;42:382
  29. Hofmann J, Fiebig HH, Winterhalter BR, Berger DP, Grunicke H. Enhancement of the antiproliferative activity of cis-diamminedichloroplatinum(II) by quercetin. Int. J. Cancer. 1990;45:536

PII: S0145-2126(02)00063-2

Leukemia Research
Volume 27, Issue 1 , Pages 65-72 , January 2003